News tagged with clinical trials
Related topics: patients , cancer , cancer cells , vaccine , food and drug administration
Icon to buy division of Cross Country Healthcare
Icon PLC plans to buy the clinical trial services division of Cross Country Healthcare Inc. in a deal potentially worth more than $55 million, as the Irish company seeks to grow globally and improve its drug safety consulting.
Other
Feb 04, 2013 |
not rated yet |
0
Ranibizumab no better than saline for vitreous hemorrhage
(HealthDay)—For patients with vitreous hemorrhage from proliferative diabetic retinopathy (PDR), the probability of vitrectomy within 16 weeks after intravitreal injections of ranibizumab or saline is lower ...
Ophthalmology
Feb 01, 2013 |
not rated yet |
0
Treatment to prevent Alzheimer's disease moves a step closer
(Medical Xpress)—A new drug to prevent the early stages of Alzheimer's disease could enter clinical trials in a few years' time according to scientists.
Alzheimer's disease & dementia
Feb 01, 2013 |
4.7 / 5 (3) |
2
Intervention helps mothers of children diagnosed with cancer
(HealthDay)—Compared with a nondirective support intervention, mothers of children recently diagnosed with cancer who participate in the Bright IDEAS problem-solving skills training (PSST) intervention ...
Cancer
Jan 31, 2013 |
5 / 5 (1) |
0
Tenofovir Gel wins out in drug absorption study, but HIV prevention trials say differently
A novel head-to-head study looking at differences in how the antiretroviral (ARV) drug tenofovir gets absorbed in the body as either an oral tablet or a vaginal gel found tenofovir gel can achieve substantially higher concentrations ...
HIV & AIDS
Jan 30, 2013 |
not rated yet |
0
Mount Sinai launches clinical trial to treat chronic pulmonary sarcoidosis
Patients are currently being enrolled in the first clinical trial to investigate the efficacy of immunological therapy for chronic pulmonary sarcoidosis. The trial is being conducted by researchers at the Icahn School of ...
Diseases, Conditions, Syndromes
Jan 30, 2013 |
not rated yet |
0
Early palliative care in lung CA focuses on coping, symptoms
(HealthDay)—Early palliative care (PC) clinic visits, integrated with standard oncologic care for patients with metastatic lung cancer, emphasize symptom management, coping, and psychosocial aspects of ...
Health
Jan 30, 2013 |
not rated yet |
0
Greater transparency needed in publishing information from clinical trials
An initiative from the drugs regulator, the European Medicines Agency, to commit to releasing all of the information from clinical trials once the marketing authorization process has ended, which has been greeted with cautious ...
Other
Jan 29, 2013 |
not rated yet |
0
Discrepant analyses of industry-sponsored clinical trials
Discrepancies between internal and published analyses of industry-sponsored clinical trials lead to further calls for transparency
Other
Jan 29, 2013 |
not rated yet |
0
Clinical trials with nonblinded outcome assessors have high observer bias
A new study of randomized clinical trials found significant observer bias toward a more beneficial treatment effect in nonblinded trials when the researcher knew the treatment being given to the participant. The study is ...
Other
Jan 28, 2013 |
not rated yet |
0
Lupus: Peptide P140/LupuzorTM effectiveness confirmed
A clinical trial with 149 patients suffering from the very disabling autoimmune disease systemic lupus erythematosus, has shown the effectiveness of a synthetic peptide developed by a team of researchers led by CNRS biologist ...
Arthritis & Rheumatism
Jan 25, 2013 |
not rated yet |
0
Discovering the secrets of tumor growth
Scientists at the University of Copenhagen's Center for Healthy Ageing have identified a compound that blocks the expression of a protein without which certain tumours cannot grow. This compound has the potential as an anticancer ...
Cancer
Jan 24, 2013 |
not rated yet |
0
Canada launches first gene therapy trial for Fabry disease
Researchers in Calgary have launched the first gene therapy clinical trial in the world for Fabry disease, a rare inherited enzyme deficiency that can shorten the lifespan of people who have it by as much as 40 years.
Diseases, Conditions, Syndromes
Jan 24, 2013 |
not rated yet |
0
Newly approved oral medication slows rheumatoid arthritis joint damage
A Phase 3 clinical trial demonstrates that tofacitinib improves disease activity and inhibits progression of joint damage in rheumatoid arthritis (RA) patients who did not respond to methotrexate (MTX). Results of the 12-month ...
Arthritis & Rheumatism
Jan 24, 2013 |
5 / 5 (1) |
0
Microdosing: Updating its role in developing new medicines
One of yesterday's most promising new tools for speeding the development of new medicines—"microdosing"—has found niches in that process today, and they include uses unanticipated a decade ago. That topic, an update on ...
Medications
Jan 23, 2013 |
not rated yet |
0
